![]() |
市場調查報告書
商品編碼
1790283
美國一次性套管針市場:按尖端、應用和細分市場進行趨勢分析:2025 年至 2033 年U.S. Disposable Trocars Market Size, Share & Trends Analysis Report By Tip, By Application, And Segment Forecasts, 2025 - 2033 |
預計 2024 年美國一次性套管針市場規模為 1.3511 億美元,到 2033 年將達到 2.0962 億美元,2025 年至 2033 年的複合年成長率為 5.00%。
市場成長的動力來自於全國大量的微創外科手術,例如腹腔鏡手術、減重手術、泌尿系統手術和泌尿外科手術,這些手術需要可靠的無菌通路設備。門診手術中心 (ASC) 的快速擴張使得感染控制、效率和周轉時間成為重中之重,進一步加速了對一次性套管針的需求。此外,醫院擴大採用達文西平台等機器人輔助手術系統,也推動了對先進光學和無刀片套管針的需求,以確保精度和相容性。嚴格的 FDA 感染控制法規和後疫情時代對無菌性的重視,使得一次性選擇比可重複使用選擇更具吸引力。同時,通用密封件和低剖面套管等持續的技術創新正在增加外科醫生的偏好並推動市場成長。
美國醫院擴大採用機器人輔助系統,例如 Intuitive Surgical 的達文西平台,這推動了對精密手術器械的需求。這些手術依賴精確的套管針定位,而光學和專用的一次性套管針與機器人器械無縫整合,使其受益匪淺。隨著先進的可視化和導航技術在外科手術中日益普及,對高性能、可增強控制性、穩定性和相容性的套管針的需求也日益成長,這使得一次性套管針在機器人輔助手術中越來越受歡迎。
美國門診手術中心 (ASC) 的快速發展推動了對一次性手術器械(尤其是套管針)的需求。 ASC 致力於最大限度地提高效率、保持無菌並降低成本,他們發現一次性套管針是符合其業務的實用解決方案。這些中心處理大量門診手術,例如疝氣修補和婦科手術,一次性套管針有助於縮短週轉時間並消除複雜的滅菌流程,最終提高手術量並保障患者安全。
美國癌症發生率的上升是一次性套管針市場的主要驅動力,因為許多腫瘤手術,例如腹腔鏡切除術、子宮切除術和切除術,都需要微創手術入路。癌症患者人數逐年增加,尤其是在高齡化社會,這推動了對安全、無菌和高效手術器械的需求。一次性套管針在這些手術中被廣泛使用,因為它們可以降低感染風險,支持複雜的手術導引,並符合醫院的腫瘤治療通訊協定。它們與機器人輔助系統和先進影像處理的兼容性,使其成為需要高精度和高控制力的癌症手術的理想選擇。
無葉片套管針技術的創新,例如無葉片尖端、光學插入系統、徑向可擴展套管以及通用密封閥,顯著提高了安全性、精準度和外科醫生的人體工學。例如,主要醫療設備製造商開發的無葉片套管針因其能夠最大限度地減少插入力和組織損傷而廣受歡迎,目前已廣泛應用於腹腔鏡手術和機器人輔助手術。
The U.S. disposable trocars market size was estimated at USD 135.11 million in 2024 and is projected to reach USD 209.62 million by 2033, growing at a CAGR of 5.00% from 2025 to 2033. The market growth is attributed to the country's high volume of minimally invasive surgical procedures, including laparoscopic, bariatric, gynecological, and urological surgeries requiring reliable and sterile access devices. The rapid expansion of ambulatory surgical centers (ASCs), where infection control, efficiency, and turnaround time are top priorities, further accelerates the demand for single-use trocars. In addition, the growing integration of robotic-assisted surgical systems in hospitals, such as the da Vinci platform, has fueled the need for advanced optical and bladeless trocars that ensure precision and compatibility. Strict FDA infection control regulations and post-COVID emphasis on sterility have made disposable options more attractive than reusable ones, while ongoing technological innovations, such as universal seals and low-profile cannulas, enhance surgeon preference and drive market growth.
The growing adoption of robotic-assisted systems such as Intuitive Surgical's da Vinci platform in U.S. hospitals drives demand for precision-compatible surgical tools. These procedures rely on accurate trocar placement and benefit significantly from optical and specialized disposable trocars that integrate seamlessly with robotic instruments. As advanced visualization and navigation technologies become more common in surgery, there is a rising need for high-performance trocars that offer enhanced control, stability, and compatibility, making disposable options increasingly preferred in robotic-assisted procedures.
The rapid growth of Ambulatory Surgical Centers (ASCs) in the U.S. fuels demand for disposable surgical devices, particularly trocars. Focused on maximizing efficiency, maintaining sterility, and reducing costs, ASCs find single-use trocars to be a practical solution that aligns with their workflow. These centers handle a high volume of outpatient procedures, such as hernia repairs and gynecological surgeries, where disposable trocars help reduce turnaround times and eliminate the need for complex sterilization processes, ultimately enhancing operational throughput and patient safety.
The rising prevalence of cancer in the U.S. is a significant driver of the disposable trocars market, as many oncologic procedures, such as laparoscopic colectomies, hysterectomies, and prostatectomies, require minimally invasive surgical access. With cancer cases increasing annually, particularly among the aging population, the demand for safe, sterile, and efficient surgical tools is growing. Disposable trocars are widely used in these procedures because they reduce the risk of infection, support complex surgical navigation, and align with hospital protocols for oncology care. Their compatibility with robotic-assisted systems and advanced imaging makes them ideal for cancer surgeries requiring high precision and control.
Innovation in trocar technology, such as bladeless tips, optical entry systems, radially expandable cannulas, and universal sealing valves, has significantly improved safety, precision, and surgeon ergonomics. These advancements contribute to better procedural outcomes and are increasingly adopted by leading hospitals across the U.S. For instance, a major medical device company's widely used bladeless trocar design has gained popularity for its ability to minimize insertion force and reduce tissue trauma, making it a preferred option in both laparoscopic and robotic-assisted surgeries.
U.S Disposable Trocars Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. disposable trocars market report on the basis of application, and tip: